Victory Capital Management
PTCT icon

Victory Capital Management’s PTC Therapeutics PTCT Stock Holding History

Victory Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
30,345
+3,092
+11% +$223K ﹤0.01% 1574
2026
Q1 		$1.86M Sell
27,253
-29,318
-52% -$2.08M ﹤0.01% 1619
2025
Q4 		$4.3M Sell
56,571
-19,542
-26% -$1.42M ﹤0.01% 1367
2025
Q3 		$4.67M Buy
76,113
+3,936
+5% +$205K ﹤0.01% 1364
2025
Q2 		$3.53M Buy
72,177
+62,915
+679% +$2.99M ﹤0.01% 1423
2025
Q1 		$472K Buy
9,262
+46
+0.5% +$2.29K ﹤0.01% 2048
2024
Q4 		$416K Sell
9,216
-227
-2% -$9.71K ﹤0.01% 2074
2024
Q3 		$350K Sell
9,443
-142
-1% -$4.75K ﹤0.01% 2097
2024
Q2 		$293K Sell
9,585
-114
-1% -$3.69K ﹤0.01% 2106
2024
Q1 		$282K Sell
9,699
-129
-1% -$3.61K ﹤0.01% 2137
2023
Q4 		$271K Buy
+9,828
New +$225K ﹤0.01% 2152
2023
Q3 		– Sell
-398,707
Closed -$16.2M – 2548
2023
Q2 		$16.2M Buy
398,707
+357,821
+875% +$17.5M 0.02% 852
2023
Q1 		$1.98M Buy
40,886
+21,350
+109% +$976K ﹤0.01% 1415
2022
Q4 		$746K Sell
19,536
-503
-3% -$20.9K ﹤0.01% 1869
2022
Q3 		$1.01M Buy
20,039
+12,021
+150% +$589K ﹤0.01% 1731
2022
Q2 		$321K Sell
8,018
-58
-0.7% -$2.03K ﹤0.01% 2213
2022
Q1 		$285K Sell
8,076
-152
-2% -$5.86K ﹤0.01% 2317
2021
Q4 		$328K Sell
8,228
-351
-4% -$13.4K ﹤0.01% 2352
2021
Q3 		$319K Sell
8,579
-413
-5% -$17K ﹤0.01% 2367
2021
Q2 		$380K Sell
8,992
-376
-4% -$16.1K ﹤0.01% 2330
2021
Q1 		$444K Sell
9,368
-6
-0.1% -$356 ﹤0.01% 2253
2020
Q4 		$572K Buy
9,374
+118
+1% +$6.96K ﹤0.01% 2014
2020
Q3 		$433K Sell
9,256
-340
-4% -$16.7K ﹤0.01% 2015
2020
Q2 		$487K Buy
9,596
+265
+3% +$13K ﹤0.01% 1992
2020
Q1 		$416K Sell
9,331
-718
-7% -$36.1K ﹤0.01% 1908
2019
Q4 		$483K Buy
10,049
+790
+9% +$33.6K ﹤0.01% 2029
2019
Q3 		$313K Buy
+9,259
New +$403K ﹤0.01% 2062

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Victory Capital Management's PTCT Position: Q2 2026 in Review

Victory Capital Management increased its PTC Therapeutics (PTCT) stake by 11% in Q2 2026, buying an estimated $223K and bringing the position to 30,345 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Victory Capital Management first reported a position in PTCT in Q3 2019 and has held it in 27 quarters since. The position peaked at $16.2M in Q2 2023. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Victory Capital Management held 30,345 shares of PTC Therapeutics worth $2.48M as of Q2 2026.
  • Victory Capital Management bought 3,092 PTC Therapeutics shares in Q2 2026, an estimated $223K.
  • PTC Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1574 holding.
  • Victory Capital Management first reported a position in PTC Therapeutics in Q3 2019 and has held it in 27 quarters since.
  • Victory Capital Management's PTC Therapeutics position peaked at $16.2M in Q2 2023.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.